Healthcare

Island Pharmaceuticals (ASX: ILA) fell 10.53% to close at 42.5 cents, a notable pullback that nonetheless leaves the stock up about 193.10% over the past twelve months — one of the stronger runs among small ASX biotechs.

Inoviq (ASX: IIQ) fell 11.58% to close at 21 cents, one of the sharper falls among ASX healthcare names in the session. The stock has had a tough year, down about 40.43% over the past twelve months.

Island Pharmaceuticals Ltd (ASX:ILA) has outlined its development strategy for Galidesivir, positioning the antiviral candidate as a potential countermeasure against multiple filovirus threats, including Ebola, Marburg and Sudan virus. The company’s July 2026 presentation focuses on the need for a broad-acting antiviral at a …

Proteomics International Laboratories Ltd (ASX:PIQ) shares climbed 19.35% to AUD 0.18 during the morning session on 8 July 2026 after the company announced that it had secured a United States patent for its PromarkerEndo diagnostic blood test. The stock gained AUD 0.030 on the …

CurveBeam AI Ltd (ASX:CVB) shares moved higher during the morning session on 8 July 2026 after the company released its Appendix 4C and quarterly activity report for the period ended 30 June 2026. The stock rose 5.56% to AUD 0.019, gaining AUD 0.0010 on …

Clinuvel Pharmaceuticals Ltd (ASX: CUV) has attracted renewed investor interest, with its shares climbing11.83% over the past monthtoAUD 10.21. Although the stock edged0.39%lower during the latest trading session, the recent rally suggests market sentiment has improved significantly.

Cochlear Ltd (ASX: COH) has staged an impressive rebound, with its shares climbing27.29% over the past monthtoAUD 127.86. The stock also advanced2.32%in the latest trading session, signalling renewed investor confidence after a challenging year.